Fair Value Calculator Fair Value Calculator
EN DE

1215 (1215) Fair Value & Analysis

Consumer Cyclical · Market cap HK$243M

1 1215 1215 · HK
PriceHK$0.0190
Fair ValueHK$0.0180
Upside-5.2%
Quality42/100
Evidence: Low Range HK$0.0169 – HK$0.0190

Fair value as of: Jul 2, 2026

From 4 valuation models · updated today

Share price −5.0% over the past month.

Price vs Fair Value (12 months)

HK$0.0310 HK$0.0130 Fair Value HK$0.0180 Jun 2025 Jun 2026

12‑month range HK$0.0130 – HK$0.0310 · fair‑value band HK$0.0169 – HK$0.0190 · the HK$0.0190 price screens above the HK$0.0180 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1215 (1215) currently trades at HK$0.0190, while our model-based Fair Value estimate is HK$0.0180 — implying the stock looks roughly 5.2% overvalued today. We read business quality at 42/100 (below-average quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, 1215 generated revenue of HK$192M at a net margin of -66.4%. Revenue declined 34.7% year over year. It earns a return on equity of -6.8%. Net debt stands at HK$649M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$192M
Revenue growth (YoY) -34.7%
Net margin -66.4%
Return on equity -6.8%
Free cash flow −HK$81.2M FY2025
Operating margin -6.0%
More key figures
EPS (TTM) HK$-0.0100
Net debt HK$649M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1215 reported revenue of HK$192M in FY2025 versus HK$93.9M in FY2021, a compound +19.6%/yr. Reported net income was −HK$128M in FY2025.

Revenue +19.6%/yr
FY21 HK$93.9M
FY22 HK$154M
FY23 HK$294M
FY24 HK$323M
FY25 HK$192M
Net income
FY21 −HK$164M
FY22 −HK$41.1M
FY23 −HK$2.4M
FY24 HK$35.8M
FY25 −HK$128M

Is 1215 fairly valued? → Check now

Similar stocks

6 more Lodging stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock Price Fair Value vs Fair Value
Marriott International, Inc MAR $392.51 $99.13 -75%
Hilton Worldwide Holdings HLT $338.22 $107.21 -68%
InterContinental Hotels Group IHG $171.02 $76.89 -55%
Hyatt Hotels Corporation H $185.21 $129.11 -30%
H World Group H1TH34 R$62.64 R$80.20 +28%
Accor SA ACRFF $57.35 $44.83 -22%

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is 1215 (1215) undervalued?
As of Jul 2, 2026, our model estimates a fair value of HK$0.0180 versus a price of HK$0.0190 — about −5% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 1215?
Our model-based fair value for 1215 is HK$0.0180 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.0190.
What is the quality score of 1215?
1215 has a Quality Score of 42/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of 1215 (1215)?
1215 reported trailing-twelve-month revenue of about HK$192M (latest available figure, as of Jul 2, 2026).
What is the net profit margin of 1215?
The net profit margin of 1215 is about -66.4%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.